Literature DB >> 7642258

Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages.

E S Drazek1, H S Houng, R M Crawford, T L Hadfield, D L Hoover, R L Warren.   

Abstract

We constructed a defined purine-auxotrophic mutant of Brucella melitensis 16M by chromosomal gene replacement. We electroporated B. melitensis 16M with suicide plasmids containing a kanamycin resistance cassette that replaced 226 bp at the carboxyl end of purE, the intergenic region, and 18 bases of the purK open reading frame. Recombinant B. melitensis delta purE201 required exogenous purines for growth on minimal media. Purine auxotrophy was complemented by electroporation of B. melitensis delta purE201 failed to grow in human monocyte-derived macrophages, while the growth of wild-type 16M and the complemented strain, delta purE201 (pSD5), increased by nearly two logs. These results suggest that B. melitensis delta purE201 will be attenuated in animals and humans and thus may be useful as a live attenuated vaccine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642258      PMCID: PMC173454          DOI: 10.1128/iai.63.9.3297-3301.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Pathogenesis of Brucella.

Authors:  L D Smith; T A Ficht
Journal:  Crit Rev Microbiol       Date:  1990       Impact factor: 7.624

2.  Preferential inhibition of primary granule release from bovine neutrophils by a Brucella abortus extract.

Authors:  T A Bertram; P C Canning; J A Roth
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice.

Authors:  D O'Callaghan; D Maskell; F Y Liew; C S Easmon; G Dougan
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

4.  Inhibition of phagosome-lysosome fusion in macrophages by soluble extracts of virulent Brucella abortus.

Authors:  P J Frenchick; R J Markham; A H Cochrane
Journal:  Am J Vet Res       Date:  1985-02       Impact factor: 1.156

Review 5.  Vaccines, vaccination in brucellosis.

Authors:  M Plommet; A Serre; R Fensterbank
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Jan-Feb

6.  Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium.

Authors:  W C McFarland; B A Stocker
Journal:  Microb Pathog       Date:  1987-08       Impact factor: 3.738

7.  Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.

Authors:  D F Sigwart; B A Stocker; J D Clements
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

8.  Salmonella typhimurium loci involved in survival within macrophages.

Authors:  A J Bäumler; J G Kusters; I Stojiljkovic; F Heffron
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes.

Authors:  L K Riley; D C Robertson
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

10.  Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.

Authors:  F R Noriega; J Y Wang; G Losonsky; D R Maneval; D M Hone; M M Levine
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more
  24 in total

1.  Growth of Brucella abortus in macrophages from resistant and susceptible mouse strains.

Authors:  J Sathiyaseelan; X Jiang; C L Baldwin
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.

Authors:  L E Lindler; T L Hadfield; B D Tall; N J Snellings; F A Rubin; L L Van De Verg; D Hoover; R L Warren
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis.

Authors:  N F Cheville; S C Olsen; A E Jensen; M G Stevens; A M Florance; H S Houng; E S Drazek; R L Warren; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Survival of a bacterioferritin deletion mutant of Brucella melitensis 16M in human monocyte-derived macrophages.

Authors:  P A Denoel; R M Crawford; M S Zygmunt; A Tibor; V E Weynants; F Godfroid; D L Hoover; J J Letesson
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

5.  Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.

Authors:  Xinghong Yang; Beata Clapp; Theresa Thornburg; Carol Hoffman; David W Pascual
Journal:  Vaccine       Date:  2016-09-14       Impact factor: 3.641

6.  Lymphocyte proliferative responses of goats vaccinated with Brucella melitensis 16M or a delta purE201 strain.

Authors:  S C Olsen; N F Cheville; M G Stevens; H H Houng; E S Drazek; T L Hadfield; R L Warren; D L Hoover
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

Authors:  D L Hoover; R M Crawford; L L Van De Verg; M J Izadjoo; A K Bhattacharjee; C M Paranavitana; R L Warren; M P Nikolich; T L Hadfield
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 8.  Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.

Authors:  R Martin Roop; Jennifer M Gaines; Eric S Anderson; Clayton C Caswell; Daniel W Martin
Journal:  Med Microbiol Immunol       Date:  2009-09-22       Impact factor: 3.402

9.  Comparison of genomes of Brucella melitensis M28 and the B. melitensis M5-90 derivative vaccine strain highlights the translation elongation factor Tu gene tuf2 as an attenuation-related gene.

Authors:  Fangkun Wang; Zujian Qiao; Sen Hu; Wenxing Liu; Huajun Zheng; Sidang Liu; Xiaomin Zhao; Zhigao Bu
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

10.  Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model.

Authors:  Rosemarie B Alcantara; Richard D A Read; Michelle Wright Valderas; Timothy D Brown; R Martin Roop
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.